A plain language summary of results from the NeoADAURA study: treatment with osimertinib before surgery for patients with EGFR-mutated non-small cell lung cancer that can be surgically removed

Jianxing He, Walter Weder, Ke-Neng Chen, Maximilian J. Hochmair, Jin-Yuan Shih, Sung Yong Lee, Kang-Yun Lee, Viet Nhung Nguyen, Somcharoen Saeteng, Lunxu Liu, Ligang Xing, Nguyen Hoang Gia, Shuji Murakami, Yongtao Han, María Paz Saavedra, Seong Hoon Yoon, Carlos H.A. Teixeira, Carles Escriu, Alex Martinez-Martí, Collin M. Blakely, Yasushi Yatabe, Sanja Dacic, Yuri Rukazenkov, Xiangning Huang, Anupriya Dayal, Jamie E. Chaft, Unknown

Open source

DOI
10.1080/14796694.2026.2739188
Published
2026-09-26
Container
Future Oncology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2026.2739188,
  title = {A plain language summary of results from the NeoADAURA study: treatment with osimertinib before surgery for patients with EGFR-mutated non-small cell lung cancer that can be surgically removed},
  author = {Jianxing He and Walter Weder and Ke-Neng Chen and Maximilian J. Hochmair and Jin-Yuan Shih and Sung Yong Lee and Kang-Yun Lee and Viet Nhung Nguyen and Somcharoen Saeteng and Lunxu Liu and Ligang Xing and Nguyen Hoang Gia and Shuji Murakami and Yongtao Han and María Paz Saavedra and Seong Hoon Yoon and Carlos H.A. Teixeira and Carles Escriu and Alex Martinez-Martí and Collin M. Blakely and Yasushi Yatabe and Sanja Dacic and Yuri Rukazenkov and Xiangning Huang and Anupriya Dayal and Jamie E. Chaft and Unknown},
  year = {2026},
  journal = {Future Oncology},
  doi = {10.1080/14796694.2026.2739188},
  url = {https://doi.org/10.1080/14796694.2026.2739188}
}

RIS

TY  - JOUR
TI  - A plain language summary of results from the NeoADAURA study: treatment with osimertinib before surgery for patients with EGFR-mutated non-small cell lung cancer that can be surgically removed
AU  - Jianxing He
AU  - Walter Weder
AU  - Ke-Neng Chen
AU  - Maximilian J. Hochmair
AU  - Jin-Yuan Shih
AU  - Sung Yong Lee
AU  - Kang-Yun Lee
AU  - Viet Nhung Nguyen
AU  - Somcharoen Saeteng
AU  - Lunxu Liu
AU  - Ligang Xing
AU  - Nguyen Hoang Gia
AU  - Shuji Murakami
AU  - Yongtao Han
AU  - María Paz Saavedra
AU  - Seong Hoon Yoon
AU  - Carlos H.A. Teixeira
AU  - Carles Escriu
AU  - Alex Martinez-Martí
AU  - Collin M. Blakely
AU  - Yasushi Yatabe
AU  - Sanja Dacic
AU  - Yuri Rukazenkov
AU  - Xiangning Huang
AU  - Anupriya Dayal
AU  - Jamie E. Chaft
AU  - Unknown
PY  - 2026
JO  - Future Oncology
DO  - 10.1080/14796694.2026.2739188
UR  - https://doi.org/10.1080/14796694.2026.2739188
ER  - 

APA

He, J., Weder, W., Chen, K., Hochmair, M. J., Shih, J., Lee, S. Y., Lee, K., Nguyen, V. N., Saeteng, S., Liu, L., Xing, L., Gia, N. H., Murakami, S., Han, Y., Saavedra, M. P., Yoon, S. H., Teixeira, C. H., Escriu, C., Martinez-Martí, A., Blakely, C. M., Yatabe, Y., Dacic, S., Rukazenkov, Y., Huang, X., Dayal, A., Chaft, J. E., & Unknown (2026). A plain language summary of results from the NeoADAURA study: treatment with osimertinib before surgery for patients with EGFR-mutated non-small cell lung cancer that can be surgically removed. Future Oncology. https://doi.org/10.1080/14796694.2026.2739188

Source records